What Does ICD-10 Code M10 Mean?
ICD-10-CM code M10 is the category-level code for gout — a crystal-induced arthropathy caused by the deposition of monosodium urate (MSU) crystals in joints and periarticular tissue as a result of hyperuricemia. M10 covers acute gouty arthritis flares across multiple etiological subtypes and joint sites. The category is not itself billable; coders must assign a specific, complete subcode that captures the cause type, joint location, and laterality.
Key attributes of the M10 category:
- Valid for: Acute gout presentations and flare encounters
- Billable at: 4th, 5th, or 6th character level (never at M10 alone)
- Applicable settings: Outpatient, inpatient, emergency, and specialist office visits
- Not valid for: Chronic or tophaceous gout (see M1A series)
What Conditions and Diagnoses Does the M10 Code Family Cover?
The M10 category captures acute gouty arthritis across five primary etiological subtypes. Each subtype is then further extended by joint site and laterality for full code specificity.
The M10 subcategories and their covered conditions include:
- M10.0 — Idiopathic gout: Primary gout with no identified underlying cause; also referred to as primary gout or gouty arthritis NOS
- M10.1 — Lead-induced gout: Secondary gout attributable to chronic lead exposure or lead nephropathy; saturnine gout
- M10.2 — Drug-induced gout: Hyperuricemia and resulting gouty arthritis caused by a medication (e.g., diuretics, cyclosporine, low-dose aspirin)
- M10.3 — Gout due to renal impairment: Urate retention from reduced glomerular filtration; commonly seen in chronic kidney disease (CKD) patients
- M10.4 — Other secondary gout: Gout attributable to other identifiable conditions not classified under M10.1–M10.3
- M10.9 — Gout, unspecified: Used only when type and specificity are entirely absent from provider documentation
What Does the M10 Code Family Exclude?
- Chronic gout — coded under M1A (with or without tophi notation)
- Tophaceous gout — M1A series, not M10
- Pseudogout / calcium pyrophosphate crystal deposition (CPPD) — coded under M11.2-
- Hyperuricemia without gout signs — coded under E79.0
- Gout-associated nephropathy — requires an additional code such as N08
When Is M10 the Right Code — and When Is M1A Correct?
This is the single most common decision point coders face with gout-related encounters, and it is also the most frequently miscoded category in rheumatology and primary care billing. Use this numbered selection process for every gout encounter:
- Review the provider’s clinical language — does the note specify “acute attack,” “flare,” “acute gouty arthritis,” or simply “gout”?
- Identify whether chronicity is stated — terms like “chronic gout,” “ongoing gout,” or “recurrent gout managed with urate-lowering therapy” push the encounter toward M1A.
- Look for documentation of tophi — visible or confirmed subcutaneous deposits are a definitive indicator of M1A.
- Default to M10 for acute flare encounters when the provider documents an acute presentation without explicit reference to chronic or tophaceous disease.
- Default to M10.9 only when the provider documents gout with no further detail and a query to the provider is not feasible.
How Does M10 (Acute Gout) Differ From M1A (Chronic Gout)?
| Feature | M10 (Acute Gout) | M1A (Chronic Gout) |
|---|---|---|
| Disease phase | Acute flare / active attack | Chronic, ongoing condition |
| Tophi noted? | Typically absent | Present or absent (7th character specifies) |
| Urate-lowering therapy ongoing? | Not necessarily | Usually documented |
| Coding interval | Per-episode | Ongoing diagnosis |
| 7th character (tophi)? | No | Yes — 0 = without tophi, 1 = with tophi |
| Common clinical language | “Acute gout,” “gout attack,” “flare” | “Chronic gout,” “tophaceous gout,” “recurrent gout” |
In practice, coders encounter provider notes that simply say “gout” with no qualifier. Auditors flag these encounters when M1A is assigned without documentation of chronicity — and equally when M10.9 is repeatedly assigned across multiple encounters without any attempt to query for specificity.
How Do You Select the Most Specific M10 Subcode?
Selecting the correct M10 subcode requires three data points from the clinical documentation. Follow this workflow:
- Determine etiology — Is the gout primary (idiopathic) or secondary (caused by a drug, lead, or renal impairment)? This determines the 4th character (M10.0–M10.4).
- Identify the affected joint — The 5th character designates joint site: unspecified site (0), shoulder (1), elbow (2), wrist (3), hand (4), hip (5), knee (6), ankle and foot (7), vertebrae (8), or multiple sites (9).
- Apply laterality — Where required, the 6th character specifies right (1), left (2), or unspecified (9). For bilateral involvement, assign separate codes for each side.
Common M10 subcodes reference table:
| Code | Description |
|---|---|
| M10.00 | Idiopathic gout, unspecified site |
| M10.071 | Idiopathic gout, right ankle and foot |
| M10.072 | Idiopathic gout, left ankle and foot |
| M10.20 | Drug-induced gout, unspecified site |
| M10.261 | Drug-induced gout, right knee |
| M10.30 | Gout due to renal impairment, unspecified site |
| M10.371 | Gout due to renal impairment, right ankle and foot |
| M10.9 | Gout, unspecified |
What Is the Correct Subcode When Type or Site Is Undocumented?
When documentation gaps prevent full specificity, apply these fallback rules:
- If etiology is known but joint site is not documented, assign the unspecified-site variant (e.g., M10.00 for idiopathic, M10.20 for drug-induced)
- If joint is known but laterality is absent, assign the unspecified laterality subcode and consider a provider query for future encounters
- If neither etiology nor site is documented, assign M10.9 — but flag for a clinical documentation improvement (CDI) query
- Never assign M10.9 when the provider note contains enough information to support a more specific code
What Documentation Is Required to Support an M10 Code?
What Must the Provider Document in the Clinical Notes?
Adequate documentation for any M10 code requires the following elements. Coders should treat this as a pre-coding checklist:
- Diagnosis stated explicitly as gout (or gouty arthritis) by the treating provider
- Acute or active nature of the presentation (e.g., “acute gout flare,” “presenting with gout attack”)
- Joint site involved — specific anatomy preferred (e.g., “first metatarsophalangeal joint,” not just “foot”)
- Laterality — right, left, or bilateral clearly noted
- Etiology or contributing cause, when known (e.g., “gout secondary to furosemide use,” “nephrogenic gout with CKD stage 3”)
- Absence of chronic or tophaceous disease, or explicit differentiation from previous chronic gout management
Which Diagnostic or Lab Findings Support This Diagnosis?
Supporting clinical findings that validate an M10 code selection include:
- Serum uric acid level (hyperuricemia, typically >6.8 mg/dL in men; note that uric acid may normalize during a flare)
- Synovial fluid analysis showing needle-shaped, negatively birefringent monosodium urate crystals under polarized light — the gold standard
- Imaging findings — plain radiographs showing soft tissue swelling; dual-energy CT (DECT) detecting urate deposits in acute or recurrent cases
- Clinical response to colchicine or NSAIDs — sometimes used as indirect diagnostic support when crystal analysis is not performed
- Joint aspiration documentation when performed
What Is the Documentation Standard for Inpatient vs. Outpatient Settings?
| Setting | Standard | Coder Action |
|---|---|---|
| Outpatient | Code based on confirmed, documented diagnoses only. Do not code “rule-out” or “probable” gout | Assign M10 code only when gout is explicitly stated as the diagnosis |
| Inpatient | Uncertain diagnoses may be coded if documented as “probable” or “suspected” by the attending physician at discharge | M10 may be assigned for “probable” acute gout per UHDDS and ICD-10-CM guidelines Section II.H |
| Emergency Department | Treat as outpatient — code confirmed diagnoses only | Code “acute joint pain” with a secondary note for suspected gout if gout is not confirmed |
How Does the M10 Code Family Affect Medical Billing and Claims?
Gout affects an estimated 9.2 million adults in the United States, according to CDC surveillance data, making it one of the most commonly billed inflammatory arthropathy conditions in outpatient and rheumatology settings. Accurate M10 code selection directly affects claim acceptance rates, medical necessity determination, and downstream quality reporting.
Key billing considerations for M10 claims:
- M10.9 (unspecified) has a higher claim scrutiny rate among commercial payers — specificity reduces the risk of a medical necessity challenge
- For drug-induced gout (M10.2), the causative drug should be identified with an additional code from the Table of Drugs and Chemicals (T36–T65) per ICD-10-CM convention
- For gout due to renal impairment (M10.3), code the underlying CKD stage (N18.1–N18.6) as an additional code
- When gout affects multiple joints in a single encounter, assign a code for each affected joint — do not default to “multiple sites” (M10.X9) if individual joint documentation supports separate coding
What CPT Codes Are Commonly Billed Alongside M10 Codes?
| CPT Code | Description | Typical Pairing Context |
|---|---|---|
| 99213–99215 | Office/outpatient E&M visit | Established patient gout management or acute flare evaluation |
| 20610 | Arthrocentesis, major joint | Joint aspiration for synovial fluid analysis or steroid injection during flare |
| 20600 | Arthrocentesis, small joint | Aspiration of MTP joint (big toe) during acute podagra flare |
| 86431 | Rheumatoid factor | Ordered to rule out RA when joint presentation is atypical |
| 84550 | Uric acid, blood | Serum urate level monitoring, commonly ordered at gout encounters |
| 81001 | Urinalysis, microscopic | Renal function screening in M10.3 encounters |
Are There Prior Authorization or Coverage Restrictions?
- Medicare (CMS): Most gout-related E&M encounters do not require prior authorization; however, biologic urate-lowering agents (e.g., pegloticase) billed under a gout diagnosis may require prior authorization under Part B
- Commercial payers: Arthrocentesis (20610/20600) with a gout diagnosis is generally covered without prior authorization but may require documentation of conservative treatment failure for repeat procedures
- Medicaid: Coverage and PA requirements vary by state; drug-induced gout encounters (M10.2) should include the medication causation documentation to support medical necessity reviews
What Coding Errors Should You Avoid With M10 Codes?
The following errors represent the highest-frequency findings in coding audits involving the M10 family:
- Assigning M10 for documented chronic gout — if the record clearly indicates ongoing, chronic disease or tophaceous deposits, M1A is required
- Using M10.9 as a default when adequate specificity exists in the provider note — this is the most prevalent documentation-related denial trigger in rheumatology claims
- Omitting laterality when a specific joint is documented — M10.071 (right ankle/foot) is not interchangeable with M10.072 (left ankle/foot) for claims processing
- Failing to sequence secondary gout correctly — for M10.2 (drug-induced), the adverse effect code from the Table of Drugs and Chemicals must be coded in addition to, not instead of, the gout code
- Coding M10.3 without supporting CKD documentation — the renal impairment must be explicitly documented to support this subcode selection
- Upcoding joint involvement — assigning a multi-site code when only one joint is documented, or assigning a named joint code without provider documentation of that specific joint
What Do Auditors Look for When Reviewing M10 Claims?
- Mismatch between specificity of ICD-10 code and clinical documentation (e.g., right ankle code with no laterality in the note)
- Repeated use of M10.9 across multiple encounters for the same patient without a CDI query pattern
- Missing etiology codes for secondary gout (M10.1–M10.4) encounters — specifically, absent adverse effect codes for drug-induced cases
- Arthrocentesis billed same-day as an E&M without a modifier 25 on the E&M claim
- Inpatient “probable” gout coded as confirmed without attending physician attestation at discharge
How Does M10 Relate to Other ICD-10 Codes?
| Related Code | Relationship Type | Key Distinction |
|---|---|---|
| M1A.- | Excludes 1 (separate code, not both) | Chronic gout — use instead of M10 when chronicity or tophi is documented |
| M11.2- | Excludes 1 | Calcium pyrophosphate crystal deposition (CPPD/pseudogout) — different crystal type, different code |
| E79.0 | Related condition, code additionally | Hyperuricemia without signs of inflammatory arthritis — when gout is not yet present |
| N08 | Manifestation — code first underlying gout | Glomerular disorders in gout; requires M10.- as the etiology (code first) |
| G99.0 | Manifestation — code first underlying gout | Autonomic neuropathy in gout |
| N22 | Manifestation — code first underlying gout | Calculus of urinary tract in gout (uric acid kidney stones) |
| Z87.39 | Personal history code | Personal history of musculoskeletal disease — may be used when gout is resolved |
What Is the Correct Code Sequencing When M10 Appears With Other Diagnoses?
- M10 as the principal diagnosis: When the gout flare is the reason for the encounter, sequence the specific M10 subcode first
- Drug-induced gout (M10.2): Sequence M10.2X (gout) first, followed by the adverse effect code from T36–T65 with the 7th character “A” (initial encounter) or “D” (subsequent)
- Gout due to renal impairment (M10.3): Sequence M10.3X (gout) and the underlying renal condition (N18.-) per the “use additional code” instruction in the tabular
- Gout with manifestation codes (N08, G99.0): Sequence the M10 etiology code first; the manifestation code follows with “code first” instruction noted in the tabular
- Comorbid chronic kidney disease: Assign CKD code in addition to M10.3 — the two are not mutually exclusive
Real-World Coding Scenario — Applying M10 in Practice
Patient encounter: A 58-year-old male presents to his primary care provider with a 48-hour history of severe pain, erythema, and swelling in his right first metatarsophalangeal (MTP) joint. The provider documents “acute gout flare, right great toe” and notes that the patient has been on hydrochlorothiazide for hypertension for the past year. Serum uric acid is 8.9 mg/dL. No prior gout history is documented, and no tophi are noted on exam. The provider orders colchicine and documents a plan to reassess urate levels at follow-up.
Correct Code Application
- M10.271 — Drug-induced gout, right ankle and foot (the right first MTP joint falls under the “ankle and foot” subsite; the cause is the thiazide diuretic)
- T50.2X5A — Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter (hydrochlorothiazide adverse effect — required additional code per M10.2 tabular instruction)
- I10 — Essential (primary) hypertension (underlying condition for which the diuretic is prescribed)
Common Mistake in This Scenario
- Incorrect code assigned: M10.9 (gout, unspecified) or M10.071 (idiopathic gout, right ankle and foot)
- Why it fails: M10.9 ignores documented etiology (drug-induced). M10.071 incorrectly classifies the gout as idiopathic when the provider clearly links it to hydrochlorothiazide use. Both errors result in missing the required adverse effect code, creating a sequencing deficiency and potential medical necessity documentation gaps that trigger payer audits.
Frequently Asked Questions About ICD-10 Code M10
Is the M10 Code Family Still Valid for 2026?
The M10 code family remains valid and fully active for fiscal year 2026, effective October 1, 2025, with no deletions or description changes to the core subcodes. Coders should verify annually against the ICD-10-CM Official Coding Guidelines released by CMS to confirm no additions or revisions have been applied to site-specific or laterality subcodes within the category.
What Is the Difference Between M10 and M1A?
M10 codes are used for acute gouty arthritis flares, while M1A codes designate chronic gout — a distinct clinical state involving recurrent or persistent urate deposition. M1A codes include a 7th character to indicate whether tophi are present (1) or absent (0), a level of specificity that does not exist in M10. Assigning M10 when the record documents chronic gout is a frequent audit error.
Can I Use M10.9 for Every Gout Encounter to Avoid Specificity Errors?
M10.9 should be used only when provider documentation contains no further detail about the type, location, or cause of gout. Using M10.9 as a default coding strategy — even when joint site and etiology are clearly documented — constitutes under-coding and may expose a practice to audit scrutiny or payment adjustments under revenue cycle compliance reviews.
When Should I Query the Provider Instead of Defaulting to an Unspecified Code?
A clinical documentation improvement (CDI) query is appropriate when the provider documents a specific joint on exam or in the assessment but fails to state laterality, or when the encounter notes reference a medication known to cause hyperuricemia (suggesting drug-induced gout) but the provider has not linked it. Querying is always preferable to repeated use of unspecified codes across an ongoing patient relationship.
Does Drug-Induced Gout (M10.2) Require an Additional Code?
Yes. Per the ICD-10-CM tabular instruction at M10.2, coders must assign an additional code from the Table of Drugs and Chemicals to identify the drug responsible. The adverse effect code requires the 7th character to reflect the encounter type. Omitting this code is one of the most commonly cited sequencing deficiencies in gout coding audits.
Is It Correct to Code Both M10.3 and a CKD Code Together?
Yes — coding M10.3 (gout due to renal impairment) alongside the appropriate N18 code (chronic kidney disease) is required, not optional. The ICD-10-CM “use additional code” instruction at M10.3 directs coders to identify the specific type of renal impairment. These codes are complementary, not mutually exclusive, and together support medical necessity for both the gout management and renal monitoring services provided at the encounter.
Key Takeaways
Accurate M10 coding is more nuanced than selecting a gout code from a lookup table. Every coder working with this category should internalize these core points:
- M10 is for acute gout only — chronic or tophaceous gout belongs in M1A, which includes tophi notation
- Etiology, joint site, and laterality are all required for full code specificity; M10.9 is a last resort, not a default
- Secondary gout codes (M10.1–M10.4) require additional codes — drug adverse effects or underlying renal conditions must be coded alongside them
- Sequencing matters — for manifestation codes (N08, G99.0), M10 is always the etiology and is sequenced first
- Auditors target M10.9 overuse and laterality mismatches — specificity is your primary audit risk management strategy
- Documentation queries are a legitimate and recommended tool when provider notes support a specific code but lack explicit language to confirm it
For additional coding guidance on inflammatory arthropathies, review the ICD-10-CM Official Coding Guidelines Section I.C.13 (Diseases of the Musculoskeletal System and Connective Tissue), available through CMS.gov, and consult AHA Coding Clinic advisories for case-specific gout coding guidance.
Content is intended for educational use by medical coders, billers, and revenue cycle professionals. Always verify code validity and guidelines against the current-year ICD-10-CM Official Coding Guidelines and your organization’s compliance policies.
